Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of KW-6485P (topiramate) in pediatric localization-related epilepsy
jRCT2080221158Phase 3
- Sponsor
- Kyowa Kirin
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of topiramate in Focal Onset Epilepsy, focal-onset epileptic seizures and focal to bilateral tonic-clonic seizure, sponsored by Kyowa Kirin.
02
Drugs
topiramate
03
Conditions
Focal Onset Epilepsyfocal-onset epileptic seizuresfocal to bilateral tonic-clonic seizure
Beyond the preview
Go deeper on jRCT2080221158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221158.